Related Experiment Videos
Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test
Laurence A Cole1, Sarah A Khanlian, Almareena Giddings
1USA hCG Reference Service, Department of Obstetrics and Gynecology, MSC10 5580 1, University of New Mexico, Albuquerque, NM 87131-0001, USA. larry@hcglab.com
Gynecologic Oncology
|April 25, 2006
Summary
Persistent low hCG levels in women often lead to unnecessary chemotherapy and surgery due to misdiagnosis. This study identifies causes and offers guidelines to prevent unwarranted treatments for false-positive human chorionic gonadotropin (hCG) results.
Area of Science:
- Reproductive Endocrinology
- Gynecologic Oncology
- Clinical Chemistry
Background:
- Persistent low levels of human chorionic gonadotropin (hCG) in women without confirmed pregnancy or malignancy often lead to aggressive, unwarranted treatment.
- This study aims to clarify the causes of persistent low hCG and establish management guidelines to prevent unnecessary interventions.
Observation:
- The USA hCG Reference Service evaluated 170 women with persistent low hCG levels (≥3 months).
- Of these, 7.6% had true malignancies, while the majority had false-positive hCG, quiescent gestational trophoblastic disease (GTD), or pituitary hCG.
- Many patients with false-positive or quiescent GTD hCG levels received ineffective chemotherapy or surgery.
Findings:
- False-positive hCG results were common, often identified incidentally via pregnancy tests.
- Quiescent GTD was frequently misidentified, leading to unnecessary treatments, particularly in patients monitored post-hydatidiform mole or GTD treatment.
- Pituitary hCG was observed in peri- and post-menopausal women, with some receiving unwarranted chemotherapy.
Implications:
- Clinicians must avoid assuming pregnancy or GTD based solely on hCG levels, especially when clinical evidence is lacking.
- Implementing proposed guidelines can prevent unnecessary and ineffective treatments for women with persistent low hCG.
- Accurate diagnosis through clinical assessment and biochemical tests is crucial before initiating therapy for suspected malignancy.